Contract manufacturing pharma player Akums Drugs & Pharmaceuticals Ltd announced that it has received the license to manufacture and commercialise bempedoic acid, a novel, oral non-statin lipid-lowering treatment option. Bempedoic acid is a new class of drug for treating high LDL-cholesterol conditions. It said that the bempedoic acid is known to be low risk for patients with intolerability for statins and is an important ingredient in most lipid-lowering drugs. Over 272 out of every lakh of people have heart disease and with every fourth death in India is caused by heart alignment. Of these, some patients may also be intolerant to statins while others may already be prescribed the maximum dose they can tolerate in the course of their treatment. For such patients, bempedoic acid will be a great alternative for doctors. Sandeep Jain, founder, promoter and director, Akums Drugs & Pharmaceuticals, said that as per statistics, there
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!